1. Pediatric superior vena cava syndrome: An evidence-based systematic review of the literature.
- Author
-
Nossair F, Schoettler P, Starr J, Chan AKC, Kirov I, Paes B, and Mahajerin A
- Subjects
- Adolescent, Age of Onset, Anticoagulants therapeutic use, Catheterization, Central Venous adverse effects, Child, Child, Preschool, Evidence-Based Medicine, Heart Defects, Congenital complications, Hematologic Neoplasms complications, Humans, Infant, Infant, Newborn, Prevalence, Prognosis, Risk Factors, Stents, Thrombophilia complications, Treatment Outcome, Vascular Surgical Procedures, Superior Vena Cava Syndrome classification, Superior Vena Cava Syndrome epidemiology, Superior Vena Cava Syndrome etiology, Superior Vena Cava Syndrome therapy
- Abstract
Superior vena cava syndrome (SVCS) results in vascular, respiratory, and neurologic compromise. A systematic search was conducted to determine the prevalence of pediatric SVCS subtypes and identify clinical characteristics/treatment strategies that may influence overall outcomes. Data from 101 case reports/case series (142 patients) were analyzed. Morbidity (30%), mortality (18%), and acute complications (55%) were assessed as outcomes. Thrombosis was present in 36%, with multi-modal anticoagulation showing improved outcome by >50% (P = 0.004). Infant age (P = 0.04), lack of collaterals (P = 0.007), acute complications (P = 0.005), and clinical presentation may have prognostic utility that could influence clinical decisions and surveillance practices in pediatric SVCS., (© 2018 Wiley Periodicals, Inc.)
- Published
- 2018
- Full Text
- View/download PDF